Zenith Contract Services

J.B. Hunt Announces Safety and Sustainability Leadership Changes

Retrieved on: 
Thursday, December 14, 2023
Professional Services, Other Transport, Trucking, Rail, Maritime, Air, Transport, Logistics, Supply Chain Management, Environment, Human Resources, Sustainability, Carbon, Safety, J. B. Hunt, Policy, Woodruff, Carbon footprint, White, JBHT, Zenith Contract Services, Management

In just four years after joining the company, he was named Chief Safety Officer, a newly created position at J.B. Hunt and one of the industry’s first.

Key Points: 
  • In just four years after joining the company, he was named Chief Safety Officer, a newly created position at J.B. Hunt and one of the industry’s first.
  • Harper and Woodruff worked alongside each other for many years to create and advance the company’s safety culture.
  • Woodruff has dedicated his 36-year career at J.B. Hunt to building the strong safety culture the company has today.
  • Woodruff is a well-known proponent for motor carrier safety, having served on several safety policy boards and committees.

Global Peptide Therapeutics Markets, Drug Dosage, Price & Clinical Trials Insights, 2029 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 6, 2023
Pharmaceutical, Health, Clinical Trials, Peptide, Drug development, Research, Safety, Indication, AstraZeneca, Disease, Patient, Medicine, Intelligence, USD, Country, Machine learning, Eli Lilly, Therapy, Cancer, Zenith Contract Services, Growth, Biomarker, AI, Knowledge, Environment, Fine chemical, Pharmaceutical industry

The "Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering.
  • Peptide drugs provide a precise and personalized approach to therapy, from treating metabolic abnormalities to tackling complex diseases like cancer.
  • The escalating interest of large pharmaceutical companies in peptide drugs is evident from the rapidly expanding global pipeline of peptide therapeutics.
  • Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029 Reports Findings & Highlights:
    Global Peptide Therapeutics Market Opportunity: > USD 80 Billion By 2029
    Insight On Peptides In Clinical Trials By Country, Indication & Phase: > 900 Peptides In Trials
    Comprehensive Insight On Peptides Drugs Available in Market: > 200 Peptides

Spacelabs Healthcare Receives Innovative Technology Designation from Vizient for the Rothman® Index

Retrieved on: 
Tuesday, November 28, 2023
Technology, Managed Care, Medical Devices, General Health, Professional Services, Hospitals, Nursing, Medical Supplies, Data Analytics, Cardiology, Health, Health Technology, Software, Other Health, Hardware, Data Management, Practice Management, Safety, Federal Medical Centres, Patient safety, EMR, Patient, Spacelabs Healthcare, FDA, OSI Systems, Zenith Contract Services, Health care, Rothman Healthcare, Vizient, Inc.

Spacelabs Healthcare , a division of OSI Systems, Inc., announces its Rothman Index clinical decision support system has received an Innovative Technology designation for its predictive analytics technology from Vizient, Inc. , the largest provider-driven healthcare performance improvement company in the country.

Key Points: 
  • Spacelabs Healthcare , a division of OSI Systems, Inc., announces its Rothman Index clinical decision support system has received an Innovative Technology designation for its predictive analytics technology from Vizient, Inc. , the largest provider-driven healthcare performance improvement company in the country.
  • Spacelabs Healthcare exhibited the Rothman Index at the Vizient Innovative Technology Exchange October 17 in Dallas.
  • Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of healthcare organizations.
  • Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

Superior Drilling Products Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 9, 2023
Machine Tools, Metalworking & Metallurgy, Mining, Minerals, Oil, Gas, Manufacturing, Natural Resources, Energy, Other Manufacturing, Adjustment, National Association, Composition, Tax, SDP, SG, EBITDA, Zenith Contract Services, Webcast, Depreciation, Capital expenditure, Table, DNR, Capital, Bookkeeping, Pharmaceutical industry, Bank

During the third quarter of 2023, the Company received $199 thousand from a non-management shareholder due to short-swing SEC profit rules.

Key Points: 
  • During the third quarter of 2023, the Company received $199 thousand from a non-management shareholder due to short-swing SEC profit rules.
  • Partially offsetting those gains was a $43 thousand expense due to an early redemption fee as part of the Company’s debt refinancing during the quarter.
  • Reaffirmed 2023 guidance (As of November 9, 2023)
    1See “Forward Looking Non-GAAP Financial Measures” below for additional information about this non-GAAP measure.
  • Contract Services revenue is comprised of repair and manufacturing services for drill bits and other tools or products for customers.

Exro Provides Operations Update with Letter to Shareholders

Retrieved on: 
Thursday, October 26, 2023
Vicinity Motor Corp., OEM, Certification, Conference, Frustration, AB, UL, HB4, TSX, Coil, Zenith Contract Services, Cell, EMS, Partnership, Deutsche Bank, LINK, Deutsche Bank Center, Traction, Electronics, Weakness, Noise, NDA, Aircraft, DFM, Collection, SEA, Lifting, Communication, Telephone numbers in South Africa, Rail transport, Cryptocurrency, Q2, European, Surroundings

CALGARY, AB, Oct. 26, 2023 /PRNewswire/ - Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the "Company" or "Exro"), a leading clean-technology company that develops new generation power-control electronics that expand the capabilities of electric motors and batteries, today provided a Q4 2023 letter to shareholders.

Key Points: 
  • CALGARY, AB, Oct. 26, 2023 /PRNewswire/ - Exro Technologies Inc. (TSX: EXRO) (OTCQB: EXROF) (the "Company" or "Exro"), a leading clean-technology company that develops new generation power-control electronics that expand the capabilities of electric motors and batteries, today provided a Q4 2023 letter to shareholders.
  • At Exro, we are significantly reshaping the way the world consumes energy, solving these key challenges slowing adoption.
  • I end by referencing the 2023 Strategic Objectives outlined in our January Letter to Shareholders ( LINK ).
  • Given the current market backdrop we will continue to evaluate optimal timing for shareholders to complete our up-list.

Experienced Business Development Leader Joins Sage Product Development, Inc. in Key Vice President Role

Retrieved on: 
Tuesday, October 24, 2023
Business development, Zenith Contract Services, Patient, Marketing, Health, Engineering, Risk management, Sage

FOXBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ -- Sage Product Development, Inc., a leading medical device contract product development and early-stage manufacturing firm, is excited to announce the appointment of Laurie Bourgeois as Vice President of Business Development.

Key Points: 
  • FOXBOROUGH, Mass., Oct. 24, 2023 /PRNewswire/ -- Sage Product Development, Inc., a leading medical device contract product development and early-stage manufacturing firm, is excited to announce the appointment of Laurie Bourgeois as Vice President of Business Development.
  • With a proven track record of cultivating strong business relationships and driving business growth, Laurie brings a wealth of experience and expertise to the Sage team.
  • In her new role, Laurie is responsible for leading the company's business development and marketing efforts, with a focus on fostering client relationships and identifying new opportunities for Sage to service client companies.
  • Laurie brings to Sage a distinguished career in driving medical device contract services business development and navigating complex market dynamics.

Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH

Retrieved on: 
Monday, October 16, 2023
Atmosphere of Earth, The Queen's Award for Enterprise: Innovation (Technology) (2007), Nitric oxide, Hospital, AUC, Ino, Zenith Contract Services, DSM-IV codes, Patient safety, Patient, Atmosphere, Pharmaceutical industry, Nursing, Vizient, Inc.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program.

Key Points: 
  • Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient’s Innovative Technology Program.
  • “We're very happy and honored to be awarded an Innovative Technology contract from Vizient for our LungFit device.
  • Through its Innovative Technology Program , Vizient works with hospital experts on its customer-led councils and task forces to evaluate products for their potential to bring real innovation to health care.
  • Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

EXPRESSION SYSTEMS INTRODUCES CHEMICALLY DEFINED INSECT CELL CULTURE MEDIUM FOR SUPERIOR PROTEIN EXPRESSION YIELDS

Retrieved on: 
Thursday, October 5, 2023
Gene, VSA, CFR, Cell, Mesa, Zenith Contract Services, Virus, ISO, Growth, ESF, BEVS, Sf9 (cells), Vaccine, Fine chemical, Spodoptera

DAVIS, Calif., Oct. 5, 2023 /PRNewswire/ -- Expression Systems, an Advancion company, today introduced a new, chemically defined insect cell culture medium that offers exceptional performance while improving the consistency and efficiency of gene therapy and other biologics manufacturing processes.  

Key Points: 
  • ESF AdvanCD™ is a 100% chemically defined, animal-origin-free, protein-free, serum-free insect cell culture medium for use in viral vector manufacturing, structural biology and other applications
    DAVIS, Calif., Oct. 5, 2023 /PRNewswire/ -- Expression Systems, an Advancion company, today introduced a new, chemically defined insect cell culture medium that offers exceptional performance while improving the consistency and efficiency of gene therapy and other biologics manufacturing processes.
  • ESF AdvanCD™ chemically defined insect cell culture medium is a proprietary formulation manufactured exclusively by Expression Systems, a leading global provider of specialty cell culture media formulations, cell lines, and contract services for the baculovirus expression platform.
  • The ESF AdvanCD cell culture medium supports scalable baculovirus infection and protein expression in Spodoptera and Trichoplusia cell lines.
  • "ESF AdvanCD cell culture medium is the next generation of Expression Systems' best-in-class products for developing and producing advanced therapies leveraging the productivity advantages of the BEVS platform," said Dr. Thera Mulvania, President, Expression Systems.

Fresenius Kabi Selected for Second Consecutive Year to Exhibit the Ivenix Infusion System at Vizient Innovative Technology Exchange

Retrieved on: 
Monday, October 2, 2023
Medical Supplies, Health, Medical Devices, Health Technology, Other Health, Pharmaceutical, Vitamins, Supplements, Fresenius (company), Massachusetts Innovation & Technology Exchange, Pump, Vizient, Inc., Mohawk Innovative Technology, Exchange, BSN, Kabi, Zenith Contract Services, RN, MHA, Safety, Pharmaceutical industry, Nursing, Medical device

Fresenius Kabi has been selected to exhibit its Ivenix Infusion System at the Vizient Innovative Technology Exchange.

Key Points: 
  • Fresenius Kabi has been selected to exhibit its Ivenix Infusion System at the Vizient Innovative Technology Exchange.
  • The Ivenix Infusion System from Fresenius Kabi is designed to overcome deficiencies in legacy infusion pumps.
  • “We are excited to return to the Vizient Innovative Technology Exchange to demonstrate how the Ivenix Infusion System can help provide ease of use with infusion delivery.”
    “The Exchange is an exciting part of the Vizient Innovative Technology Program, which results in Innovative Technology contract awards for the qualified products.
  • Since 2003, Vizient has reviewed over 1,600 product submissions as part of its Innovative Technology Program.

Global Metal Additive Manufacturing Markets Report 2023: From the $5.4B Topline 2023 Market Size, the Report Sees $3.2B for Contract Services, $1.3B for Hardware, and $920M for Materials - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 28, 2023
Machine Tools, Metalworking & Metallurgy, Manufacturing, EOS, Metal, Business analyst, Printing, 3D, Polymer, Research, AMR, History, Forecasting, GE Aviation, Zenith Contract Services, SLM Solutions Group AG, Data, Growth, Sierra, 3D Systems, R, BLT, Rare-earth element, Renewable energy, 3D printing

The "Metal Additive Manufacturing Markets 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Metal Additive Manufacturing Markets 2023" report has been added to ResearchAndMarkets.com's offering.
  • The metal 3D printing market is expected to achieve significantly more growth in 2023 compared to the total AM market (which would include polymers and other materials).
  • Growth is expected to be powered by the actual use of metal AM processes rather than by R&D
    The report analyzes the challenges and opportunities facing metal additive manufacturing (AM) stakeholders in light of current market forces.
  • The latest forecasts in the report expect the metal AM market to achieve significantly more growth in 2023 compared to the total additive market overall.